J2280
HCPCSInj, moxifloxacin 100 mg
Official HCPCS Level II long descriptor
Injection, moxifloxacin, 100 mg
HCPCS Level II code J2280 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj, moxifloxacin 100 mg
Added to HCPCS: 2004-01-01
Nearby codes in J2
- J2260Inj milrinone lactate / 5 mg
- J2265Minocycline hydrochloride
- J2267Inj, mirikizumab-mrkz, 1 mg
- J2270Morphine sulfate injection
- J2272Inj, morphine (fresenius)
- J2274Inj morphine pf epid ithc
- J2277Inj, motixafortide, 0.25 mg
- J2278Ziconotide injection
- J2281Inj moxifloxacin (fres kabi)
- J2290Inj, nafcillin sodium, 20 mg
- J2291Inj, nafcillin (baxter) 20mg
- J2300Inj nalbuphine hydrochloride
- J2305Inj, nitroglycerin, 5 mg
- J2312Inj naloxone hcl nos, 0.01mg
- J2313Inj, naloxone (zimhi) 0.01mg
- J2315Naltrexone, depot form
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.